Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

IBD medications during pregnancy and lactation

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Too many people with viral hepatitis are diagnosed late - with dire consequences

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Many European countries 'flying blind' in their efforts to eliminate viral hepatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. NAFLD: Cardiovascular complications of NAFLD-they do matter

    Research output: Contribution to journalLetterResearchpeer-review

  4. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Viral hepatitis: Cell-culture-derived HCV--a promising vaccine antigen

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Managing vitamin D deficiency in inflammatory bowel disease

    Research output: Contribution to journalReviewResearchpeer-review

  2. Metabonomics in Gastroenterology and Hepatology

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Methotrexate for inflammatory bowel disease: time for reconsideration

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
IBD often affects patients during their peak reproductive years. Several drugs are available for the treatment of IBD and new drugs are continuously in the pipeline. As long-term administration of medications is often necessary, the safety of drug therapy during pregnancy and breast-feeding needs to be considered in daily clinical practice. The aim of this Review is to summarize the latest information concerning the safety of medications used to treat IBD during pregnancy and lactation, as well as their effect on fertility. Although only thalidomide and methotrexate are absolutely contraindicated during pregnancy and breast-feeding, alternatives to ciprofloxacin, natalizumab and sodium phosphate should also be considered for pregnant women. Breast-feeding is also discouraged while on treatment with ciclosporin, metronidazole and ciprofloxacin. However, therapy with 5-aminosalicylic acid preparations, glucocorticoids, thiopurines and TNF inhibitors are acceptable during pregnancy and lactation. Pregnant women who have symptomatic IBD or who require therapy should have the opportunity to discuss any associated risks to their pregnancy and infant with the appropriate consultants. By ensuring that the patient and her family are informed, the clinical outcome might be optimized.
Original languageEnglish
JournalNature Reviews. Gastroenterology & Hepatology
Volume11
Issue number2
Pages (from-to)116-127
Number of pages12
ISSN1759-5045
DOIs
Publication statusPublished - 2014

ID: 38907531